Literature DB >> 1285889

Pregnancy and scleroderma.

A J Silman1.   

Abstract

Scleroderma is a rare disease with a marked female excess in incidence. The pattern of age of onset, together with the effects of the disease, are such that the majority of women with scleroderma experience pregnancy prior to diagnosis. There are three questions of interest: (1) Does pregnancy adversely affect the prognosis of scleroderma? Isolated case reports suggest that renal disease, and in particular hypertensive crises, are associated with pregnancy in the absence of any renal abnormality before pregnancy. However, such events are rare. (2) Does scleroderma adversely affect either fertility or the outcome of pregnancy? Women with established scleroderma, again in case series, have a high rate of spontaneous miscarriage which is not found consistently in epidemiological studies. Prematurity and low birth rates are more frequent problems. (3) Does reproductive history influence disease and particularly Raynaud's phenomenon may antedate diagnosis by many years and might influence reproductive outcome, in general reproductive outcome is similar to that seen after diagnosis, although fertility appears to be reduced.

Entities:  

Mesh:

Year:  1992        PMID: 1285889     DOI: 10.1111/j.1600-0897.1992.tb00802.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  3 in total

1.  Influence of prior pregnancies on disease course and cause of death in systemic sclerosis.

Authors:  C M Artlett; M Rasheed; K E Russo-Stieglitz; H H B Sawaya; S A Jimenez
Journal:  Ann Rheum Dis       Date:  2002-04       Impact factor: 19.103

2.  Prevalence and clinical associations with primary hypogonadism in male systemic sclerosis.

Authors:  Sapol Thepwiwatjit; Suranut Charoensri; Wichien Sirithanaphol; Ajanee Mahakkanukrauh; Siraphop Suwannaroj; Chingching Foocharoen
Journal:  J Scleroderma Relat Disord       Date:  2022-07-24

Review 3.  [Systemic sclerosis and pregnancy. A review of the current literature].

Authors:  A Németh; S Szamosi; A Horváth; J Schönherr; E Nicksch; Z Szekanecz; G Szűcs
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.